INmune Bio Signs Uniphar Deal to Build Global Access Route…
Key Facts INmune Bio (NASDAQ: INMB) has signed a Master Services Agreement with Uniphar Durbin Ireland Limited covering international access, distribution and commercialisation of Ebstrocel™. Ebstrocel™ is an investigational allogeneic…